{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T03:31:26Z","timestamp":1788838286941,"version":"build-2803163510"},"reference-count":84,"publisher":"Bentham Science Publishers Ltd.","issue":"15","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDT"],"published-print":{"date-parts":[[2019,11,12]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>Dengue fever is a disease which is caused by a family of viruses named Flaviviridae which\nare transmitted by female Aedes mosquitoes. Today, this is endemic in more than 100 nations in the\nWorld Health Organization&amp;#039;s African, Americas, Eastern Mediterranean, South-East Asia and Western\nPacific locales. The treatment of typical dengue is focused on relieving the symptoms and signs. Carica\npapaya is a very common plant whose leaf extract is used in the treatment of this disease. Despite\nextensive research on Dengue, not a single vaccine or anti-viral drug was available until 2016 (a partially\neffective Chimeric Yellow fever virus treated by DENV-Tetravalent Dengue Vaccine for dengue\nfever made by Sanofi Pasteur). This review highlights dengue fever\u2019s current situation and explains\nthe importance of Natural chemical moieties like methionine\u2013proline anilides, tetrapeptide aldehyde\nuncovered via Structure Activity Relationship studies. Also, we have reviewed the drug candidates\ncurrently in the clinical trials that have the potential to solve these issues. Important patents in the past\n20 years have been outlined in this review. An in depth Protein Data Bank analysis of the different\npossible target proteins that can potentially have a major role in curing Dengue fever has been conducted.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1389450120666190724145937","type":"journal-article","created":{"date-parts":[[2019,7,24]],"date-time":"2019-07-24T18:24:09Z","timestamp":1563992649000},"page":"1550-1562","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["A Multi-Perspective Review on Dengue Research"],"prefix":"10.2174","volume":"20","author":[{"given":"M. Elizabeth","family":"Sobhia","sequence":"first","affiliation":[{"name":"Department of Pharmacoinformatics, National Institute of Pharmaceutical Education and Research, Mohali, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ketan","family":"Ghosh","sequence":"additional","affiliation":[{"name":"Department of Pharmacoinformatics, National Institute of Pharmaceutical Education and Research, Mohali, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajeet","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Pharmacoinformatics, National Institute of Pharmaceutical Education and Research, Mohali, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Komal","family":"Sul","sequence":"additional","affiliation":[{"name":"Department of Pharmacoinformatics, National Institute of Pharmaceutical Education and Research, Mohali, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Pharmacoinformatics, National Institute of Pharmaceutical Education and Research, Mohali, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Pharmacoinformatics, National Institute of Pharmaceutical Education and Research, Mohali, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Sandeep","sequence":"additional","affiliation":[{"name":"Department of Pharmacoinformatics, National Institute of Pharmaceutical Education and Research, Mohali, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satti","family":"Merugu","sequence":"additional","affiliation":[{"name":"Department of Pharmacoinformatics, National Institute of Pharmaceutical Education and Research, Mohali, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunilchand","family":"Donempudi","sequence":"additional","affiliation":[{"name":"Department of Pharmacoinformatics, National Institute of Pharmaceutical Education and Research, Mohali, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1038\/nrmicro2460","volume":"8","author":"Guzman M.G.","year":"2010","unstructured":"Guzman M.G.; Halstead S.B.; Artsob H.; Dengue: a continuing global threat. Nat Rev Microbiol 2010,8(12)(Suppl.),S7-S16","journal-title":"Nat Rev Microbiol"},{"key":"ref=2","first-page":"e105","volume":"8","author":"Heilman J.M.","year":"2014","unstructured":"Heilman J.M.; De Wolff J.; Beards G.M.; Basden B.J.; Dengue fever: a Wikipedia clinical review. Open Med 2014,8(4),e105-e115","journal-title":"Open Med"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1128\/CMR.11.3.480","volume":"11","author":"Gubler D.J.","year":"1998","unstructured":"Gubler D.J.; Dengue and dengue hemorrhagic fever. Clin Microbiol Rev 1998,11(3),480-496","journal-title":"Clin Microbiol Rev"},{"key":"ref=4","year":"2017","unstructured":"2017"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/S2221-1691(11)60055-5","volume":"1","author":"Ahmad N.","year":"2011","unstructured":"Ahmad N.; Fazal H.; Ayaz M.; Abbasi B.H.; Mohammad I.; Fazal L.; Dengue fever treatment with Carica papaya leaves extracts. Asian Pac J Trop Biomed 2011,1(4),330-333","journal-title":"Asian Pac J Trop Biomed"},{"key":"ref=6","author":"Bleijas D.A.","year":"2018","unstructured":"Bleijas D.A.;  2018"},{"key":"ref=7","author":"Bleijas D.A.","year":"2018","unstructured":"Bleijas D.A.;  2018"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"337","DOI":"10.2147\/IDR.S55376","volume":"7","author":"Gupta E.","year":"2014","unstructured":"Gupta E.; Ballani N.; Current perspectives on the spread of dengue in India. Infect Drug Resist 2014,7,337-342","journal-title":"Infect Drug Resist"},{"key":"ref=9","first-page":"1","author":"Fusco D.","year":"2014","unstructured":"Fusco D.; Chung R.; Review of current dengue treatment and therapeutics in development. J Bioanal Biomed 2014(8),1","journal-title":"J Bioanal Biomed"},{"key":"ref=10","first-page":"S96","author":"Low JG","year":"2017","unstructured":"Low JG; Ooi EE; Vasudevan SG; Current status of dengue therapeutics research and development. J Infect Dis (8)2017(2),S96-S102","journal-title":"J Infect Dis"},{"key":"ref=11","first-page":"1001","volume":"1","author":"Hitesh A.","year":"2017","unstructured":"Hitesh A.; Solanki, Shetty Shilpa Shankar, Himanshu A. Pandya. Dengue as a druggable disease: A review. J Fever 2017,1(1),1001","journal-title":"J Fever"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.str.2012.01.001","volume":"20","author":"Cockburn J.J.","year":"2012","unstructured":"Cockburn J.J.; Navarro Sanchez M.E.; Fretes N.; Mechanism of dengue virus broad cross-neutralization by a monoclonal antibody. Structure 2012,20(2),303-314","journal-title":"Structure"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"4971","DOI":"10.4049\/jimmunol.1200227","volume":"188","author":"Midgley C.M.","year":"2012","unstructured":"Midgley C.M.; Flanagan A.; Tran H.B.; Structural analysis of a dengue cross-reactive antibody complexed with envelope domain III reveals the molecular basis of cross-reactivity. J Immunol 2012,188(10),4971-4979","journal-title":"J Immunol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1002\/prot.24237","volume":"81","author":"Elahi M.","year":"2013","unstructured":"Elahi M.; Islam M.M.; Noguchi K.; Yohda M.; Kuroda Y.; High resolution crystal structure of dengue-3 envelope protein domain III suggests possible molecular mechanisms for serospecific antibody recognition. Proteins 2013,81(6),1090-1095","journal-title":"Proteins"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1128\/JVI.02957-12","volume":"87","author":"Klein D.E.","year":"2013","unstructured":"Klein D.E.; Choi J.L.; Harrison S.C.; Structure of a dengue virus envelope protein late-stage fusion intermediate. J Virol 2013,87(4),2287-2293","journal-title":"J Virol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nature02165","volume":"427","author":"Modis Y.","year":"2004","unstructured":"Modis Y.; Ogata S.; Clements D.; Harrison S.C.; Structure of the dengue virus envelope protein after membrane fusion. Nature 2004,427(6972),313-319","journal-title":"Nature"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.bbrc.2016.01.159","volume":"471","author":"Kulkarni M.R.","year":"2016","unstructured":"Kulkarni M.R.; Numoto N.; Ito N.; Kuroda Y.; Modeling and experimental assessment of a buried Leu-Ile mutation in dengue envelope domain III. Biochem Biophys Res Commun 2016,471(1),163-168","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1126\/science.1153263","volume":"319","author":"Li L.","year":"2008","unstructured":"Li L.; Lok S-M.; Yu I-M.; The flavivirus precursor membrane-envelope protein complex: structure and maturation. Science 2008,319(5871),1830-1834","journal-title":"Science"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"4285","DOI":"10.1073\/pnas.1322036111","volume":"111","author":"Edeling M.A.","year":"2014","unstructured":"Edeling M.A.; Diamond M.S.; Fremont D.H.; Structural basis of Flavivirus NS1 assembly and antibody recognition. Proc Natl Acad Sci USA 2014,111(11),4285-4290","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1126\/science.1247749","volume":"343","author":"Akey D.L.","year":"2014","unstructured":"Akey D.L.; Brown W.C.; Dutta S.; Flavivirus NS1 structures reveal surfaces for associations with membranes and the immune system. Science 2014,343(6173),881-885","journal-title":"Science"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/nsmb1073","volume":"13","author":"Erbel P.","year":"2006","unstructured":"Erbel P.; Schiering N.; D\u2019Arcy A.; Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus. Nat Struct Mol Biol 2006,13(4),372-373","journal-title":"Nat Struct Mol Biol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1128\/JVI.02044-09","volume":"84","author":"Chandramouli S.","year":"2010","unstructured":"Chandramouli S.; Joseph J.S.; Daudenarde S.; Gatchalian J.; Cornillez-Ty C.; Kuhn P.; Serotype-specific structural differences in the protease-cofactor complexes of the dengue virus family. J Virol 2010,84(6),3059-3067","journal-title":"J Virol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.1038\/emboj.2008.232","volume":"27","author":"Luo D.","year":"2008","unstructured":"Luo D.; Xu T.; Watson R.P.; Insights into RNA unwinding and ATP hydrolysis by the flavivirus NS3 protein. EMBO J 2008,27(23),3209-3219","journal-title":"EMBO J"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.ejmech.2016.10.007","volume":"125","author":"Benmansour F.","year":"2017","unstructured":"Benmansour F.; Trist I.; Coutard B.; Discovery of novel dengue virus NS5 methyltransferase non-nucleoside inhibitors by fragment-based drug design. Eur J Med Chem 2017,125,865-880","journal-title":"Eur J Med Chem"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.antiviral.2014.03.013","volume":"106","author":"Coutard B.","year":"2014","unstructured":"Coutard B.; Decroly E.; Li C.; Assessment of Dengue virus helicase and methyltransferase as targets for fragment-based drug discovery. Antiviral Res 2014,106,61-70","journal-title":"Antiviral Res"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.antiviral.2014.09.003","volume":"111","author":"Noble C.G.","year":"2014","unstructured":"Noble C.G.; Li S-H.; Dong H.; Chew S.H.; Shi P.Y.; Crystal structure of dengue virus methyltransferase without S-adenosyl-L-methionine. Antiviral Res 2014,111,78-81","journal-title":"Antiviral Res"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"6233","DOI":"10.1074\/jbc.M110.179184","volume":"286","author":"Lim S.P.","year":"2011","unstructured":"Lim S.P.; Sonntag L.S.; Noble C.; Small molecule inhibitors that selectively block dengue virus methyltransferase. J Biol Chem 2011,286(8),6233-6240","journal-title":"J Biol Chem"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"5291","DOI":"10.1128\/JVI.00045-13","volume":"87","author":"Noble C.G.","year":"2013","unstructured":"Noble C.G.; Lim S.P.; Chen Y-L.; Conformational flexibility of the Dengue virus RNA-dependent RNA polymerase revealed by a complex with an inhibitor. J Virol 2013,87(9),5291-5295","journal-title":"J Virol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.jmb.2007.07.005","volume":"372","author":"Egloff M-P.","year":"2007","unstructured":"Egloff M-P.; Decroly E.; Malet H.; Structural and functional analysis of methylation and 5\u2032-RNA sequence requirements of short capped RNAs by the methyltransferase domain of dengue virus NS5. J Mol Biol 2007,372(3),723-736","journal-title":"J Mol Biol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"4753","DOI":"10.1128\/JVI.02283-06","volume":"81","author":"Yap T.L.","year":"2007","unstructured":"Yap T.L.; Xu T.; Chen Y-L.; Crystal structure of the dengue virus RNA-dependent RNA polymerase catalytic domain at 1.85-angstrom resolution. J Virol 2007,81(9),4753-4765","journal-title":"J Virol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"3414","DOI":"10.1073\/pnas.0305892101","volume":"101","author":"Ma L.","year":"2004","unstructured":"Ma L.; Jones C.T.; Groesch T.D.; Kuhn R.J.; Post C.B.; Solution structure of dengue virus capsid protein reveals another fold. Proc Natl Acad Sci USA 2004,101(10),3414-3419","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"4609","DOI":"10.1128\/JVI.02424-12","volume":"87","author":"Xie X.","year":"2013","unstructured":"Xie X.; Gayen S.; Kang C.; Yuan Z.; Shi P.Y.; Membrane topology and function of dengue virus NS2A protein. J Virol 2013,87(8),4609-4622","journal-title":"J Virol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nature12060","volume":"496","author":"Bhatt S.","year":"2013","unstructured":"Bhatt S.; Gething P.W.; Brady O.J.; The global distribution and burden of dengue. Nature 2013,496(7446),504-507","journal-title":"Nature"},{"key":"ref=34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001760","volume":"6","author":"Brady O.J.","year":"2012","unstructured":"Brady O.J.; Gething P.W.; Bhatt S.; Refining the global spatial limits of dengue virus transmission by evidence-based consensus. PLoS Negl Trop Dis 2012,6(8)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=35","unstructured":""},{"key":"ref=36","year":"2016","unstructured":"Distribution of Dengue worldwide2016"},{"key":"ref=37","year":"2015","unstructured":"Dengue Cases and Deaths in the Country since2015"},{"key":"ref=38","unstructured":""},{"key":"ref=39","author":"Setthapramote C","unstructured":"Setthapramote C; Sasaki T; Kuhara M; Dengue-virus serotype neutralizing antibodies. inventors; Google Patents, assignee."},{"key":"ref=40","author":"Luke Robinson ZS","year":"2015","unstructured":"Luke Robinson ZS; Google Patent, assignee Antibody molecules to\ndengue virus and uses thereof MyetteGregory, BabcockKarthik, Viswanathan. inventor;2015"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1056\/NEJMoa1503877","volume":"374","author":"L\u2019Azou M.","year":"2016","unstructured":"L\u2019Azou M.; Moureau A.; Sarti E.; Symptomatic dengue in children in 10 Asian and Latin American countries. N Engl J Med 2016,374(12),1155-1166","journal-title":"N Engl J Med"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1093\/infdis\/jiv082","volume":"212","author":"Kirkpatrick B.D.","year":"2015","unstructured":"Kirkpatrick B.D.; Durbin A.P.; Pierce K.K.; Robust and Balanced immune responses to all 4 dengue virus serotypes following administration of a single dose of a live attenuated tetravalent dengue vaccine to healthy, flavivirus-naive adults. J Infect Dis 2015,212(5),702-710","journal-title":"J Infect Dis"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"7126","DOI":"10.1016\/j.vaccine.2015.09.101","volume":"33","author":"Manoff S.B.","year":"2015","unstructured":"Manoff S.B.; George S.L.; Bett A.J.; Preclinical and clinical development of a dengue recombinant subunit vaccine. Vaccine 2015,33(50),7126-7134","journal-title":"Vaccine"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.vaccine.2010.11.050","volume":"29","author":"Beckett C.G.","year":"2011","unstructured":"Beckett C.G.; Tjaden J.; Burgess T.; Evaluation of a prototype dengue-1 DNA vaccine in a Phase 1 clinical trial. Vaccine 2011,29(5),960-968","journal-title":"Vaccine"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/S1473-3099(14)70730-3","volume":"14","author":"Low J.G.","year":"2014","unstructured":"Low J.G.; Sung C.; Wijaya L.; Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial. Lancet Infect Dis 2014,14(8),706-715","journal-title":"Lancet Infect Dis"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1093\/infdis\/jis470","volume":"207","author":"Nguyen N.M.","year":"2013","unstructured":"Nguyen N.M.; Tran C.N.B.; Phung L.K.; A randomized, double-blind placebo controlled trial of balapiravir, a polymerase inhibitor, in adult dengue patients. J Infect Dis 2013,207(9),1442-1450","journal-title":"J Infect Dis"},{"key":"ref=47","author":"Scott MSI","year":"2011","unstructured":"Scott MSI; Joshua C; Vaikuntanath S; Optimized dengue virus entry inhibitory\npeptide (10AN) Ekachai Jenwitheesuk inventor; Google Patent, assignee.2011"},{"key":"ref=48","author":"Setthapramote C.","year":"2013","unstructured":"Setthapramote C.; Sasaki T.; Kuhara M.; Dengue-virus serotype\nneutralizing antibodies. Google Patents 2013","journal-title":"Google Patents"},{"key":"ref=49","author":"William MNH","year":"2017","unstructured":"William MNH; Sean P; McBurney inventor; Google Patent, assignee. Dengue virus vaccine 2017","journal-title":"Dengue virus vaccine"},{"key":"ref=50","author":"Gracia Fe B","year":"2014","unstructured":"Gracia Fe B; Yu Evb; Milagros BL; Salvador C. Caoili; Diagnosis and detection\nof dengue virus infection using chicken egg antibodies JB NEVADO inventor; Google Patent, assignee2014"},{"key":"ref=51","author":"Catherine HAY SS","year":"2017","unstructured":"Catherine HAY SS; assignee Formulation\nof antibody molecules to dengue virus Bi XU inventor; Google Patent2017"},{"key":"ref=52","author":"JR John J.","year":"2014","unstructured":"JR John J.; Google Patent, assignee Virus purification and formulation process vicalvi EGH, Joseph Makowiecki inventor;2014"},{"key":"ref=53","author":"Guy RKHBL","year":"2014","unstructured":"Guy RKHBL; assignee Dengue serotype 2\nattenuated strain inventor; Google Patent2014"},{"key":"ref=54","author":"Dennis R","year":"2014","unstructured":"Dennis R; Burton P.; assignee Dengue serotype 2 attenuated strain vicalvi EGH, Joseph Makowiecki inventor; Google Patent2014"},{"key":"ref=55","author":"Lai C.J.","year":"2005","unstructured":"Lai C.J.; Purcell R.H.; Monoclonal antibodies that bind or neutralize\ndengue virus. Google Patents 2005","journal-title":"Google Patents"},{"key":"ref=56","author":"Bosch I.","year":"2017","unstructured":"Bosch I.; SchifferlI-Hamad K.; Marquez-Gomezosch J.; Antidengue\nvirus ns1 protein monoclonal antibodies. Google Patents 2017","journal-title":"Google Patents"},{"key":"ref=57","year":"2012","unstructured":"Immunologic diagnosis kit for detecting type II dengue virus NS1\nantigen. Google Patents 2012","journal-title":"Google Patents"},{"key":"ref=58","author":"Tan Y.H.","year":"1993","unstructured":"Tan Y.H.; Fu J.; Tan B.H.; Cdna sequence of dengue virus serotype\n1 (singapore strain). Google Patents 1993","journal-title":"Google Patents"},{"key":"ref=59","author":"Claire YH","unstructured":"Claire YH; Kinney ETB; Richard M.; Kinney inventor; Google\nPatent, assignee. Chimeric west nile\/dengue viruses."},{"key":"ref=60","author":"Stephen S.","unstructured":"Stephen S.; Whitehead BRM.; Kathryn A. Hanley; Joseph E. Blaney; Attenuated dengue\nvirus comprising mutations in the NS3 gene. Ching-Juh Lai inventor; Google Patent, assignee"},{"key":"ref=61","author":"Stephen S.","year":"2009","unstructured":"Stephen S.; Whitehead BRM.; Kathryn A. Hanley; Joseph E. Blaney; assignee Attenuated dengue virus comprising\nmutations in the NS3 gene inventor; Google Patent2009"},{"key":"ref=62","author":"Jill A.","year":"2016","unstructured":"Jill A.; Livengood CYHDP.; Dan T.; Compositions, methods and uses\nfor dengue virus serotype-4 constructs Stinchcomb, Jorge Osorio inventor; Google Patent, assignee2016"},{"key":"ref=63","author":"Farmer L.","year":"2003","unstructured":"Farmer L.; Pitlik J.; Perni R.; Bridged bicyclic serine protease inhibitors Google Patents 2003","journal-title":"Google Patents"},{"key":"ref=64","year":"2003","unstructured":"Process for preparing an attenuated tetravalent\ndengue vaccine. Google patent Neuza Maria. Inventor2003","journal-title":"Google patent"},{"key":"ref=65","author":"Chelsea M.Byrd","year":"2012","unstructured":"Chelsea M.Byrd; Thienopyridine derivatives for the treatment and\nprevention of dengue virus infections Google patent 2012","journal-title":"Google patent"},{"key":"ref=66","year":"2013","unstructured":"Combinations of berberine, artemisinin,\nloperamide and their derivatives to treat malaria, diarrhea, travelers'\ndiarrhea, dysentery, dengue fever, parasites, cholera and viruses. Google patent Spencer J. Inventor2013","journal-title":"Google patent"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s11418-013-0767-y","volume":"67","author":"Abd Kadir S.L.","year":"2013","unstructured":"Abd Kadir S.L.; Yaakob H.; Mohamed Zulkifli R.; Potential anti-dengue medicinal plants: a review. J Nat Med 2013,67(4),677-689","journal-title":"J Nat Med"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s000180050138","volume":"54","author":"Laille M.","year":"1998","unstructured":"Laille M.; Gerald F.; Debitus C.; \n                        In vitro antiviral activity on dengue virus of marine natural products. Cell Mol Life Sci 1998,54(2),167-170","journal-title":"Cell Mol Life Sci"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"6549","DOI":"10.1016\/j.bmcl.2013.10.071","volume":"23","author":"Zhou G-C.","year":"2013","unstructured":"Zhou G-C.; Weng Z.; Shao X.; Discovery and SAR studies of methionine-proline anilides as dengue virus NS2B-NS3 protease inhibitors. Bioorg Med Chem Lett 2013,23(24),6549-6554","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.bmcl.2005.09.049","volume":"16","author":"Yin Z.","year":"2006","unstructured":"Yin Z.; Patel S.J.; Wang W.L.; Peptide inhibitors of dengue virus NS3 protease. Part 2: SAR study of tetrapeptide aldehyde inhibitors. Bioorg Med Chem Lett 2006,16(1),40-43","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.antiviral.2009.09.007","volume":"84","author":"Kampmann T.","year":"2009","unstructured":"Kampmann T.; Yennamalli R.; Campbell P.; \n                        In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses. Antiviral Res 2009,84(3),234-241","journal-title":"Antiviral Res"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"255","DOI":"10.4103\/0972-9062.217617","volume":"54","author":"Qaddir I.","year":"2017","unstructured":"Qaddir I.; Rasool N.; Hussain W.; Mahmood S.; Computer-aided analysis of phytochemicals as potential dengue virus inhibitors based on molecular docking, ADMET and DFT studies. J Vector Borne Dis 2017,54(3),255-262","journal-title":"J Vector Borne Dis"},{"key":"ref=73","first-page":"1","volume":"5","author":"Sajin A.","year":"2015","unstructured":"Sajin A.; Rathnan R.; Mechoor A.; Molecular docking studies on phytocompounds from the methanol leaf extract of Carica papaya against envelope protein of dengue virus (type-2). J Comput Meth Mol Des 2015,5(2),1-7","journal-title":"J Comput Meth Mol Des"},{"key":"ref=74","first-page":"2119","volume":"30","author":"Qamar M.T.","year":"2017","unstructured":"Qamar M.T.; Ashfaq U.A.; Tusleem K.; \n                        In-silico identification and evaluation of plant flavonoids as dengue NS2B\/NS3 protease inhibitors using molecular docking and simulation approach. Pak J Pharm Sci 2017,30(6),2119-2137","journal-title":"Pak J Pharm Sci"},{"key":"ref=75","volume":"30","author":"Raikar S.","year":"2018","unstructured":"Raikar S.; Patil N.; Kulkarni M.; \n                        In-silico identification and evaluation of plant flavonoids as dengue NS2B\/NS3 protease inhibitors using molecular docking and simulation approach. Pak J Pharm Sci 2018,30(6)","journal-title":"Pak J Pharm Sci"},{"key":"ref=76","first-page":"1","author":"Anusuya S.","year":"2017","unstructured":"Anusuya S.; Gromiha M.M.; Structural basis of flavonoids as dengue polymerase inhibitors: insights from QSAR and docking studies. J Biomol Struct Dyn 2017,1-12","journal-title":"J Biomol Struct Dyn"},{"key":"ref=77","first-page":"895","volume":"28","author":"God\u00f3i IP","year":"2017","unstructured":"God\u00f3i IP; Lima WG; Comar M Junior; Docking and QM\/MM studies of NS2B-NS3pro inhibitors: a molecular target against the dengue virus. \u200e. J Braz Chem Soc 2017,28(5),895-906","journal-title":"J Braz Chem Soc"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3389\/fchem.2017.00088","volume":"5","author":"Halim S.A.","year":"2017","unstructured":"Halim S.A.; Khan S.; Khan A.; Targeting dengue virus ns-3 helicase by ligand based pharmacophore modeling and structure based virtual screening. Front Chem 2017,5,88","journal-title":"Front Chem"},{"key":"ref=79","author":"Toepak E.","year":"2017","unstructured":"Toepak E.; Tambunan U.; \n                        In silico design of fragment-based drug targeting host processing \u03b1-glucosidase i for dengue fever. IOP Conference Series: Materials Science and Engineering 2017","journal-title":"IOP Conference Series: Materials Science and Engineering"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"516","DOI":"10.2174\/1386207319666160506123715","volume":"19","author":"Powers C.N.","year":"2016","unstructured":"Powers C.N.; Setzer W.N.; An in-silico investigation of phytochemicals as antiviral agents against dengue fever. Comb Chem High Throughput Screen 2016,19(7),516-536","journal-title":"Comb Chem High Throughput Screen"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.2174\/138945006779025383","volume":"7","author":"Rawlinson S.M.","year":"2006","unstructured":"Rawlinson S.M.; Pryor M.J.; Wright P.J.; Jans D.A.; Dengue virus RNA polymerase NS5: a potential therapeutic target? Curr Drug Targets 2006,7(12),1623-1638","journal-title":"Curr Drug Targets"},{"key":"ref=82","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006934","volume":"14","author":"Gallichotte E.N.","year":"2018","unstructured":"Gallichotte E.N.; Baric T.J.; Yount B.L.; Human dengue virus serotype 2 neutralizing antibodies target two distinct quaternary epitopes. PLoS Pathog 2018,14(2)","journal-title":"PLoS Pathog"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"997","DOI":"10.2741\/4630","volume":"23","author":"Botta L.","year":"2018","unstructured":"Botta L.; Rivara M.; Zuliani V.; Radi M.; Drug repurposing approaches to fight Dengue virus infection and related diseases. Front Biosci 2018,23,997-1019","journal-title":"Front Biosci"},{"key":"ref=84","author":"Maria G.","year":"2015","unstructured":"Maria G.; Guzman D.;  a continuing global threat Nat Rev Microbiol Author manuscript; available in PMC2015","journal-title":"a continuing global threat Nat Rev Microbiol"}],"container-title":["Current Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/173833","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,28]],"date-time":"2019-11-28T13:26:40Z","timestamp":1574947600000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/173833\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,12]]},"references-count":84,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2019,11,12]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389450120666190724145937","relation":{},"ISSN":["1389-4501"],"issn-type":[{"value":"1389-4501","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11,12]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-04-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-07-03","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-07-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}